Esophagus Cancer Terminated Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0032126 (Esophagus Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01774851A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and StomachTreatment